PME Stock Overview
A healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Pro Medicus Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$214.62 |
| 52 Week High | AU$215.34 |
| 52 Week Low | AU$85.60 |
| Beta | 0.54 |
| 11 Month Change | 14.46% |
| 3 Month Change | 41.67% |
| 1 Year Change | 142.26% |
| 33 Year Change | 247.17% |
| 5 Year Change | 761.93% |
| Change since IPO | 15,014.08% |
Recent News & Updates
Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being
Nov 18
With EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting Case
Nov 11Recent updates
Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being
Nov 18With EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting Case
Nov 11Do Pro Medicus' (ASX:PME) Earnings Warrant Your Attention?
May 02Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today
Jan 15Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Dec 10Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors
Oct 09Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention
Aug 12Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jul 08Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
May 09Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Apr 02Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital
Jan 25We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease
Dec 13Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
Oct 26Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Sep 14Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Jul 06Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jun 15Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Mar 16Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Feb 23Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Oct 26Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively
Aug 13Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Jul 26Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency
May 07Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 15This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)
Feb 20Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Feb 18
Is Pro Medicus (ASX:PME) The Next Multi-Bagger?
Feb 01How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?
Jan 12Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?
Dec 28Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment
Dec 11Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?
Nov 26Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?
Aug 09What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?
Aug 09Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?
Jul 21How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?
Jul 03Shareholder Returns
| PME | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 4.8% | 4.7% | 1.5% |
| 1Y | 142.3% | 122.4% | 17.2% |
Return vs Industry: PME exceeded the Australian Healthcare Services industry which returned 122.4% over the past year.
Return vs Market: PME exceeded the Australian Market which returned 17.2% over the past year.
Price Volatility
| PME volatility | |
|---|---|
| PME Average Weekly Movement | 3.9% |
| Healthcare Services Industry Average Movement | 8.2% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: PME has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: PME's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | Sam Hupert | www.promed.com.au |
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products.
Pro Medicus Limited Fundamentals Summary
| PME fundamental statistics | |
|---|---|
| Market cap | AU$22.43b |
| Earnings (TTM) | AU$82.79m |
| Revenue (TTM) | AU$161.50m |
270.9x
P/E Ratio138.9x
P/S RatioIs PME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PME income statement (TTM) | |
|---|---|
| Revenue | AU$161.50m |
| Cost of Revenue | AU$301.00k |
| Gross Profit | AU$161.20m |
| Other Expenses | AU$78.41m |
| Earnings | AU$82.79m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.79 |
| Gross Margin | 99.81% |
| Net Profit Margin | 51.27% |
| Debt/Equity Ratio | 0% |
How did PME perform over the long term?
See historical performance and comparison